Are multiple mechanisms involved in FTLD-TDP pathologensis: will one drug fit all?

Status / Stage
Completed
Dates
1 February 2016 -
31 January 2020
Duration (calculated)
03 years 11 months
Funder(s)
Alzheimer's Research UK
Funding Amount
£419,995.00
Funder/Grant study page
Alzheimer's Research UK
Contracted Centre
University College London
Principal Investigator
Dr Tammaryn Lashley
PI Contact
t.lashley@ucl.ac.uk
WHO Catergories
Understanding risk factors
Understanding Underlying Disease
Disease Type
Frontotemporal Dementia (FTD)

CPEC Review Info
Reference ID229
ResearcherReside Team
Published12/06/2023

Data

Status / StageCompleted
Start Date20160201
End Date20200131
Duration (calculated) 03 years 11 months
Funder/Grant study pageAlzheimer's Research UK
Contracted CentreUniversity College London
Funding Amount£419,995.00

Aims

Investigating one of the hallmark proteins of frontotemporal dementia.Dr Tammaryn Lashley will tease apart this complexity, zeroing in on the key changes that cause nerve cells to die. The team is focusing on a particular protein called TDP-43, which is found in the brain in about half of those with FTD. Researchers don’t yet know all the different ways that TDP-43 can cause nerve cell damage, so understanding more about the key steps in the disease will help in the search for new treatments.